Please provide your email address to receive an email when new articles are posted on . Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — A percutaneous femoropopliteal bypass system appears to be feasible, according to interim results of ...
MILPITAS, Calif.--(BUSINESS WIRE)--Silicon Valley-based medical device company PQ Bypass announced today the 100th patient in the DETOUR2 Clinical Trial, which evaluates the safety and effectiveness ...
One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results